Commercial agreement with Doctors on Demand in Australia

View printer-friendly version Doctors on Demand will integrate ResAppDx and SleepCheck into its online consultation offerings Agreement includes exchange of key data to support future reimbursement submissions Doctors on Demand are one of Australia’s largest private...

Medgate extends European ResAppDx trial

View printer-friendly version Brisbane, Australia, 3 June 2021 — ResApp Health Limited (ASX:RAP), a leading digital health company developing smartphone applications for the diagnosis and management of respiratory disease, today provides an update on Medgate...

First participant recruited in COVID-19 cough study

View printer-friendly version First participant enrolled in US clinical study to investigate the relationship between cough and COVID-19 and develop an instant COVID-19 screening smartphone app Participants enrol and participate in the study using the COVID-Cough...

Agreement secured with Ilara Health to sell ResAppDx in Kenya

View printer-friendly version Ilara Health appointed to promote, market and sell ResAppDx in Kenya Ilara provides access to a large potential customer base in Kenya and has established partnerships with over 250 primary care clinics across the country Agreement...